We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

30 hedge funds and large institutions have $28.3M invested in Allena Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

20% more capital invested

Capital invested by funds: $23.6M → $28.3M (+$4.66M)

7% more funds holding

Funds holding: 28 → 30 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
10
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$3.33M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$917K
3
WVP
Worth Venture Partners
New Jersey
+$783K
4
Renaissance Technologies
Renaissance Technologies
New York
+$398K
5
BCM
Bridgeway Capital Management
Texas
+$371K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.67M
2
Morgan Stanley
Morgan Stanley
New York
-$690K
3
SM
Sabby Management
Florida
-$345K
4
AFM
Anson Funds Management
Texas
-$278K
5
Millennium Management
Millennium Management
New York
-$141K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$5.56M +$3.33M +2,000,000 +100%
FM
2
Frazier Management
Washington
$4.63M – – –
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$4.17M -$1.67M -1,000,000 -25%
TGI
4
TRV GP II
Massachusetts
$3.88M – – –
Fidelity Investments
5
Fidelity Investments
Massachusetts
$3.19M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.6M +$917K +550,562 +92%
WVP
7
Worth Venture Partners
New Jersey
$1.36M +$783K +470,000 +92%
Morgan Stanley
8
Morgan Stanley
New York
$887K -$690K -414,099 -39%
Renaissance Technologies
9
Renaissance Technologies
New York
$675K +$398K +238,919 +97%
BCM
10
Bridgeway Capital Management
Texas
$530K +$371K +222,400 +140%
PHS
11
PFM Health Sciences
California
$395K – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$356K +$274K +164,371 +179%
BlackRock
13
BlackRock
New York
$264K +$42.9K +25,746 +16%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$192K +$230K +137,900 New
Millennium Management
15
Millennium Management
New York
$148K -$141K -84,569 -44%
Northern Trust
16
Northern Trust
Illinois
$91K +$1.45K +870 +1%
Two Sigma Investments
17
Two Sigma Investments
New York
$56K +$67K +40,200 New
ECM
18
ExodusPoint Capital Management
New York
$55K +$66.2K +39,713 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$54K +$65.3K +39,186 New
GG
20
Golden Green
South Carolina
$40K -$16.7K -10,000 -26%
LPL Financial
21
LPL Financial
California
$35K – – –
Osaic Holdings
22
Osaic Holdings
Arizona
$32K +$8.33K +5,000 +28%
HF
23
HRT Financial
New York
$31K +$37.3K +22,382 New
LFF
24
Level Four Financial
Texas
$28K +$33.3K +20,000 New
Barclays
25
Barclays
United Kingdom
$13K +$15K +9,019 New
1
2

ALNA Hedge Fund Activity: Q1 2021 in Review

30 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q1 2021, worth a combined $28.3M — up 20% from $23.6M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ALNA positions and 7 closed out — a net gain of 2 holders — while 10 added to existing stakes and 6 trimmed.

The largest buyer was AIGH Capital Management, adding an estimated $3.33M. The largest seller was Point72 Asset Management, cutting an estimated $1.67M.

  • 30 institutional investors held Allena Pharmaceuticals (ALNA) as of Q1 2021, up from 28 in Q4 2020.
  • Funds reported $28.3M of Allena Pharmaceuticals stock for Q1 2021, up 20% quarter-over-quarter.
  • 9 funds opened new Allena Pharmaceuticals positions in Q1 2021 and 7 closed out, a net change of +2 holders.
  • The largest Allena Pharmaceuticals buyer in Q1 2021 was AIGH Capital Management, an estimated $3.33M added.
  • The largest Allena Pharmaceuticals seller in Q1 2021 was Point72 Asset Management, an estimated $1.67M sold.

Based on aggregated 13F filings for Q1 2021.